555
Views
7
CrossRef citations to date
0
Altmetric
Editorial

PLX4032 and melanoma: resistance, expectations and uncertainty

Pages 325-328 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Paulina Szyszka, Michal A Zmijewski & Andrzej T Slominski. (2012) New vitamin D analogs as potential therapeutics in melanoma. Expert Review of Anticancer Therapy 12:5, pages 585-599.
Read now

Articles from other publishers (5)

Songjiang Wu, Yuhan Tang & Wenli Liu. (2020) Circ_0084043 promotes cell proliferation and glycolysis but blocks cell apoptosis in melanoma via circ_0084043-miR-31-KLF3 axis. Open Life Sciences 15:1, pages 774-786.
Crossref
Hui Qian, Chen Yang & Yixin Yang. (2017) MicroRNA-26a inhibits the growth and invasiveness of malignant melanoma and directly targets on MITF gene. Cell Death Discovery 3:1.
Crossref
J. S. Fowles, C. L. Denton & D. L. Gustafson. (2015) Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma. Veterinary and Comparative Oncology 13:3, pages 288-304.
Crossref
Brian J. Nickoloff & George Vande Woude. (2012) Hepatocyte growth factor in the neighborhood reverses resistance to BRAF inhibitor in melanoma . Pigment Cell & Melanoma Research 25:6, pages 758-761.
Crossref
Zhao Wang, Jianjun Chen, Jin Wang, Sunjoo Ahn, Chien-Ming Li, Yan Lu, Vivian S. Loveless, James T. Dalton, Duane D. Miller & Wei Li. (2012) Novel Tubulin Polymerization Inhibitors Overcome Multidrug Resistance and Reduce Melanoma Lung Metastasis. Pharmaceutical Research 29:11, pages 3040-3052.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.